I upgrade VGT to a long-term buy due to its strong fundamentals, robust earnings, and leadership in tech innovation. VGT offers broad, pure tech exposure with low expenses and diversification beyond the dominant NVDA, MSFT, and AAPL holdings. The top three holdings generate massive free cash flow and continue to drive sector growth, especially with AI and cloud tailwinds.

Heads up, Elon?

I reiterate a Strong Buy on Cognex Corporation with a $51.64 price target, driven by robust U.S. reindustrialization and automation trends. Major trade deals and tariffs are fueling over $1T in U.S. investments, expanding Cognex's addressable market, especially in manufacturing and pharmaceuticals. Cognex's new leadership, AI-driven product expansion, and cloud platform OneVision position the company for accelerated growth and broader market reach.

Surmodics delivers third-quarter fiscal 2025 earnings beat with narrower loss, as revenue tops estimates despite lower SurVeil DCB sales.

KTOS' Kratos Government Solutions segment boosts defense capabilities with key tech gains, strong revenue growth and a strategic acquisition.

Kodak warned in a Securities and Exchange Commission filing that it faces serious financial concerns, citing substantial doubt about continuing operations.

PennantPark Investment Corporation (NYSE:PNNT ) Q3 2025 Earnings Conference August 12, 2025 12:00 PM ET Company Participants Arthur Howard Penn - Founder, Chairman, Managing Partner & CEO Richard Thomas Allorto - Chief Financial Officer Conference Call Participants Arren Saul Cyganovich - Truist Securities, Inc., Research Division Brian J. Mckenna - Citizens JMP Securities, LLC, Research Division Casey Jay Alexander - Compass Point Research & Trading, LLC, Research Division Christopher Whitbread Patrick Nolan - Ladenburg Thalmann & Co. Inc., Research Division Melissa Wedel - JPMorgan Chase & Co, Research Division Paul Conrad Johnson - Keefe, Bruyette, & Woods, Inc., Research Division …

AAL adds new routes to Europe and South America for summer 2026, as international air travel demand remains strong.

MAC's second-quarter FFO fell short of estimates on lower occupancy and higher expenses, but leasing activities and revenue growth offer bright spots.

AXP leverages its rewards program, premium perks and digital upgrades to retain loyalty against fintech rivals.

Angelo Zino of CFRA says Apple (AAPL) is likely to outsource A.I. to another company.

CSX Corporation (NASDAQ:CSX ) Deutsche Bank US Transportation Conference 2025 August 11, 2025 9:00 AM ET Company Participants Kevin S. Boone - Executive VP & Chief Commercial Officer Conference Call Participants Richa Harnain - Unidentified Company Richa Harnain Hello, everyone.

NEW YORK , Aug. 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: WideOpenWest, Inc. (NYSE: WOW)'s sale to affiliates of DigitalBridge Investments, LLC and Crestview Partners for $5.20 per share. If you are a WideOpenWest shareholder, click here to learn more about your rights and options.

LIVERMORE, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel cell and hydrogen technology space, announced today that it has entered into a new enhanced license agreement with TRIAD National Security for the Ion Pair technology originally developed at Los Alamos National Laboratory. In the new enhanced license, Advent acquired exclusivity to the technology in the marine, aviation, and portable power fields while retaining its non-exclusive rights in all other fields.

PHILADELPHIA , Aug. 12, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Altimmune Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Altimmune between August 10, 2023 through June 25, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Altimmune securities during the Class Period may, no later than October 6, 2025 , seek to be appointed as a lead plaintiff representative of the class.

ATLANTA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net income of $3.3 million, or $0.15 per diluted share, for the three month period ended June 30, 2025 compared to net loss of ($0.7) million, or ($0.04) per diluted share, for the comparable period in 2024. The Company had net income of $4.1 million, or $0.19 per diluted share, for the six month period ended June 30, 2025, compared to net loss of ($2.7) million, or ($0.14) per diluted share, for the six month period ended June 30, 2024. The increase in net income for …

V's $12B tech investment and AI-driven tools are blocking billions in fraud, keeping it ahead in cybersecurity innovation.

Nu Holdings' rapid customer growth, low-cost platform, and strong Q2 forecasts could set the stage for another earnings beat.

FRD delivers robust first-quarter fiscal 2026 results with rising sales, stronger margins and a sharp swing to profitability in key segments.

When it comes to curing common ailments, the majority of doctors won't be prescribing things like LSD, mescaline, PCP, or psilocybin (mushrooms) anytime soon. But these are examples of a growing billion-dollar psychedelic drugs industry that's poised for even more growth.